BioStem Technologies Reports Q3 Revenue Beat Amid Earnings Miss
BioStem Technologies (BSEM) released its third-quarter financial results, reporting a GAAP earnings per share (EPS) of -$0.64. This figure missed analyst expectations by $0.21. Despite the earnings miss, the company reported revenue of $7.64 million, which exceeded market estimates by $0.47 million. However, total revenue saw a significant year-over-year decline of 27.0%, reflecting ongoing challenges in top-line growth.

Tickers: $BSEM
Topics: earnings miss financial results GAAP EPS revenue beat